SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia has concluded its landmark debut at the BIO International Convention 2025,…